常见问题

根据肿瘤类型和位置，通常在 2 至 8 小时之间；简单的脑膜瘤切除需 2-3 小时，而深部或清醒下的胶质瘤手术可能达到 6-8 小时。手术时长本身并不是成功的指标。术后通常需要 24-48 小时重症监护，住院共 3-7 天。

不是。对某些肿瘤手术是首选，但小型无症状脑膜瘤可随访，淋巴瘤以化疗/放疗而非手术治疗，某些深部胶质瘤可能更倾向于活检和伽玛刀。正确的方法由组织学诊断和多学科评估决定。

不会。现代做法倾向于尽量少剃；在大多数情况下，只需沿切口线剃出一条窄带即可。如今很少需要剃光整个头部。

可以。您可以通过 WhatsApp（+90 533 075 72 94）发送现有的 MRI 或 CT 影像，并获得初步评估。如果合适，您将被邀请到我们位于伊兹密尔科纳克的诊所进行检查，必要时会安排进一步的影像检查。

不会。大多数动脉瘤从不破裂且未被发现；小动脉瘤（<7 毫米）的年破裂风险相当低。风险因大小、位置、家族史和增长速度而异，并借助 PHASES 评分等工具进行估计。

两者都是文献中报告成功率为 90%~95% 的有效方法；“更好”的是最适合该患者的方法。栓塞创伤较小且恢复快，但有再通风险；夹闭提供永久性解决方案但需要开颅。决策根据动脉瘤的特点和患者因素做出。

如果您出现一生中最剧烈、在数秒内开始的头痛（“头里有东西爆裂”的感觉），伴有颈强直、恶心呕吐或意识模糊，请立即前往急诊并呼叫急救。这种情况可能是动脉瘤破裂导致的蛛网膜下腔出血。

大多数动脉瘤不是遗传性的。但如果您的一级亲属有两例及以上动脉瘤或脑出血史，家族风险会增加；这种情况下可能建议进行 MRA 筛查。您可以通过 WhatsApp（+90 533 075 72 94）分享您的 MRI/CT 影像，以获得初步评估。

分流通过永久性的管-阀系统将多余的脑脊液转移到腹腔，通常终生保留。而 ETV 在脑室底部造一个孔，使人体自身的液体循环重新运作；不在体内留下异物。分流在交通性脑积水和 NPH 中较为突出，ETV 在适合的梗阻性病例中较为突出。方法根据脑积水类型和患者选择。

在大多数植入分流的患者中，由于脑脊液循环不会自行恢复，该系统是永久性的。尽管如此，绝大多数患者会回归学校、工作和日常生活；游泳、步行和骑自行车都适宜，仅不建议高冲击的接触性运动和深潜。在 ETV 成功的病例中，则可能不需要分流。

NPH 是一种可治疗的病症，通过分流，相当一部分患者的步态和认知功能有明显改善的报告；但不能保证每位患者都有相同程度的成功。为预测成功几率，可在术前进行“放液试验”。携带步态视频和近期 MRI 就诊可使评估更为便利。

您可以通过 WhatsApp（+90 533 075 72 94）发送现有的 MRI 影像（若怀疑 NPH，请另附步态视频）。如果合适，您将被邀请到我们位于伊兹密尔科纳克的诊所进行检查；必要时会安排脑脊液流动 MRI 等进一步影像检查以及放液试验。

通常不需要。小而无症状、生长缓慢的脑膜瘤可通过定期 MRI 随访，尤其在老年患者中。如果肿瘤生长、引起症状或产生压迫，则考虑手术或伽玛刀。决策根据肿瘤的大小、位置及其在随访中的表现个体化作出。

绝大多数病例（约 80-85%）为良性（世界卫生组织 1 级），并非传统意义上的癌症。较小比例表现为非典型（2 级）或恶性（3 级）。肿瘤的真实分级只有通过对手术中获取组织的病理检查才能明确。

在部分患者中可以。对于深部、手术风险高或中小型脑膜瘤，立体定向放射外科（伽玛刀、射波刀）是有效的选择。然而，对于大型、有症状或产生压迫的肿瘤，手术更为优先。何种方法合适由 MRI 和多学科评估决定。

可以。您可以通过 WhatsApp（+90 533 075 72 94）发送现有的 MRI 或 CT 影像，并获得初步评估。如果合适，您将被邀请到我们位于伊兹密尔科纳克的诊所进行检查，必要时会安排进一步的影像检查。

由于胶质母细胞瘤在显微镜层面浸润周围脑组织，单靠手术并不能提供“治愈”；因此手术后会进行放疗和化疗（Stupp 方案）。治疗的目的是控制疾病并保持生活质量。任何结果都无法保证，预期会被诚实地说明。

由于胶质母细胞瘤生长迅速，治疗通常会迅速安排。一旦诊断明确，手术以及随后的放疗-化疗阶段会毫不拖延地开始。等待多久由肿瘤位置、患者状况和多学科评估决定。

目标是在保留功能的前提下尽可能广泛的安全切除。如果肿瘤靠近言语或运动等关键区域，可能会限制切除范围以降低永久性损伤的风险。无法切除的显微病灶通过放疗和化疗加以处理。

可以。您可以通过 WhatsApp（+90 533 075 72 94）发送现有的 MRI 或 CT 影像，并获得初步评估。如果合适，您将被邀请到我们位于伊兹密尔科纳克的诊所进行检查，必要时会安排进一步的影像检查和多学科评估。

视情况而定，两者均可能正确。对于单发、大型、有症状的病灶，手术更为优先；对于中小型或少数病灶，则首选伽玛刀（立体定向放射外科）。对于超过五处的广泛转移，则考虑伽玛刀或全脑放疗。决策根据转移灶的数目、大小、位置和原发癌以多学科方式作出。

影像可提供有力线索，但并不总是确定。即使已知有癌症，脑部肿块有时也可能是另一种肿瘤（例如脑膜瘤）。对于单发病灶，手术切除既提供治疗又明确组织诊断；因此病理对于鉴别诊断很重要。

可以。即使是多发转移，也有包括伽玛刀、全脑放疗以及针对原发癌的全身治疗（靶向药物、免疫治疗）等选择。结果随原发癌的类型和分子特征而异；部分患者可实现长期控制。方案由多学科团队个体化制定。

可以。您可以通过 WhatsApp（+90 533 075 72 94）发送现有的 MRI 或 CT 影像，以及（如有）原发癌信息，并获得初步评估。如果合适，您将被邀请到我们位于伊兹密尔科纳克的诊所进行检查，必要时会安排进一步的影像检查和多学科评估。

不是。根据 2021 年世界卫生组织分类，IDH 突变型星形细胞瘤和 IDH 野生型胶质母细胞瘤被视为不同的疾病。IDH 突变型星形细胞瘤的预后明显更好。肿瘤的真实类型和级别通过对手术或活检所获组织的病理和分子检查才能明确。

决策根据肿瘤的级别、IDH 状态、位置和大小作出。虽然某些低级别肿瘤术后可密切监测，但在大多数病例中，尽可能广泛的安全切除是第一步。正确的路径由组织诊断和多学科评估决定。

目标是在保留功能的前提下尽可能广泛地切除。如果肿瘤靠近言语或运动等关键区域，会使用功能定位以及必要时的清醒开颅，并据此设定切除边界以降低永久性损伤的风险。风险会在术前坦诚讨论。

可以。您可以通过 WhatsApp（+90 533 075 72 94）发送现有的 MRI 或 CT 影像，以及（如有）病理-分子结果，并获得初步评估。如果合适，您将被邀请到我们位于伊兹密尔科纳克的诊所进行检查，必要时会安排进一步的影像检查。

确诊需要组织：根据 2021 年世界卫生组织分类，必须同时证明 IDH 突变和 1p/19q 共缺失。该组织通过手术切除或立体定向活检获取。在大多数病例中，尽可能广泛的安全切除既提供治疗又提供准确的分子诊断。

少突胶质细胞瘤在弥漫性胶质瘤中具有最佳预后，并对放疗-化疗敏感，但由于它是弥漫性肿瘤，称其为“良性”并不正确。预后随级别、切除程度和分子特征而异；建议密切随访。任何结果都无法保证。

有可能。由于其皮质位置，少突胶质细胞瘤可能在很长一段时间内仅以癫痫为唯一症状。在 MRI 上看到皮质-皮质下、常伴钙化的病灶会引起怀疑；确诊通过组织和分子检查作出。您可以发送现有的 MRI 供我们评估。

可以。您可以通过 WhatsApp（+90 533 075 72 94）发送现有的 MRI 或 CT 影像，以及（如有）病理-分子结果，并获得初步评估。如果合适，您将被邀请到我们位于伊兹密尔科纳克的诊所进行检查，必要时会安排进一步的影像检查。

No. The great majority of people with epilepsy live seizure-free on medication. Surgery is considered only in selected, drug-resistant patients whose seizures continue despite two appropriate medications and in whom a seizure focus can be identified. Suitability is determined by a multidisciplinary assessment.

In well-selected patients, especially in mesial temporal lobe epilepsy, the chance of seizure freedom or a marked reduction is high; however, no outcome can be guaranteed. Some methods, such as neuromodulation, aim at reducing seizure frequency rather than seizure freedom. Expectations are shared openly after assessment.

Medications are not stopped immediately after surgery. A gradual, careful reduction under the neurologist's supervision is considered over a seizure-free period. This decision varies from patient to patient and is never rushed.

Yes. You can send your existing MRI, EEG and any video-EEG reports via WhatsApp (+90 533 075 72 94) for a preliminary assessment. If appropriate, you will be invited to our clinic in Izmir Konak for examination, and further epilepsy-protocol investigation will be planned if needed.

No. The first step of treatment is always medication; drugs such as carbamazepine control the pain in a substantial proportion of patients. Surgery is considered only if pain persists despite an adequate dose of medication or if the patient cannot tolerate the side effects.

Microvascular decompression is an operation that removes the cause by moving the vessel compressing the nerve away; the chance of pain freedom is high and the risk of numbness low, but it is major surgery. Percutaneous procedures (balloon, glycerol, radiofrequency) are needle-based, less invasive and suitable for older patients, but carry a higher probability of facial numbness and recurrence.

In selected patients, especially those with clear vascular compression on MRI, the chance of long-term pain freedom after microvascular decompression is high; however, no method offers a lifelong guarantee, and recurrence is possible with every method. Expectations are shared openly after assessment.

Yes. If you have a trigeminal-protocol MRI you can send it via WhatsApp (+90 533 075 72 94) for a preliminary assessment. If appropriate, you will be invited to our clinic in Izmir Konak for examination, and a thin-slice MRI will be planned if needed.

No. An acoustic neuroma (vestibular schwannoma) is almost always benign, does not spread elsewhere in the body and usually grows slowly. Nevertheless, because as it grows it can press on the hearing, balance and facial nerves, assessment and, where necessary, treatment are important.

No. For small, asymptomatic tumors or those in older patients, follow-up with interval MRI may be appropriate; Gamma Knife is considered for small-to-medium tumors, and microsurgery for large or rapidly growing tumors. The correct option is determined according to tumor size, growth rate, age, hearing and symptoms.

The chance of preserving hearing is closely related to tumor size and pre-operative hearing status; in small tumors this chance is markedly higher. However, no method guarantees that hearing will be preserved. Expectations are shared openly before surgery according to your audiometry and MRI results.

Yes. If you have a contrast-enhanced MRI focused on the internal auditory canal and an audiometry result, you can send them via WhatsApp (+90 533 075 72 94) for a preliminary assessment. If appropriate, you will be invited to our clinic in Izmir Konak for examination, and further investigation will be planned if needed.

No. Prolactinoma is usually treated with medication, and small, asymptomatic adenomas may simply be followed. Surgery comes to the fore especially in adenomas causing vision loss or secreting ones such as in acromegaly/Cushing's. The decision is made multidisciplinarily according to the hormone profile, visual status and MRI findings.

For most pituitary adenomas, no. The standard method today is endoscopic transsphenoidal surgery: the tumor is reached through the nostrils, the skull is not opened and no incision scar remains on the face. Only in selected large or extensive tumors may different routes be needed.

If the vision loss is due to the tumor pressing on the optic nerves and the compression is relieved early, a marked improvement in vision is common; however, the degree of improvement depends on the duration and severity of the compression and cannot be guaranteed. This is why early assessment is important in tumors causing vision loss.

Yes. You can send your pituitary-protocol MRI, hormone blood results and any visual field test via WhatsApp (+90 533 075 72 94) for a preliminary assessment. If appropriate, you will be invited to our clinic in Izmir Konak for examination, and endocrinology and ophthalmology assessment will be planned if needed.

Neither. A cavernoma is a benign vascular structure made up of abnormal, thin-walled vessels; it is not cancer and does not spread elsewhere in the body. It also differs from a brain aneurysm: it is a low-pressure structure, usually bleeds in a more limited way and is not suitable for treatment from within the vessel (endovascular).

No. Incidentally found, asymptomatic cavernomas, or those in deep/risky regions, are generally followed with interval MRI. Surgery is considered for cavernomas located in an accessible region, causing recurrent bleeding or leading to drug-resistant seizures. The decision is made according to the location of the lesion, the history of bleeding and the symptoms.

A cavernoma bleed is mostly small and limited, but in critical regions such as the brainstem even a small bleed can lead to marked symptoms. A cavernoma that has bled once is more likely to bleed again; for this reason the history of bleeding is an important factor in the decision between observation and surgery.

Yes. You can send your existing MRI via WhatsApp (+90 533 075 72 94) for a preliminary assessment, especially if it includes the special sequences that show blood products (gradient echo / SWI). If appropriate, you will be invited to our clinic in Izmir Konak for examination, and further imaging will be planned if needed.